A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information.
All news from Immuno Haematology & Blood Transfusion
In the first peer-reviewed published report of its kind, University of Toronto researchers have demonstrated that focused ultrasound can be used to safely open the blood-brain barrier (BBB) in patients with Alzheimer's disease
The human brain, with its 100 billion neurons that control every thought, word, and action, is the most complex and in the body. Because it needs extra protection from toxins and other harmful substances, the blood vessels that supply the brain with oxygen and nutrients are highly selective about which molecules can cross from the blood into the brain and vice versa
A population of cells called macrophages coat the outer walls of healthy arteries and express a protein called LYVE-1, researchers at National University of Singapore report. The researchers found that when these cells were absent, arteries accumulate collagen and lose their elasticity, becoming stiff and inflexible.
Researchers demonstrate that a single transplantation of murine macrophages into the lungs of mice suffering from herPAP can treat this life-threatening disease
The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell disease (SCD) in individuals who do not have asthma
Glioblastoma brain tumors can have an unusual effect on the body's immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body's defenses.
Through a randomized, double-blind, placebo-controlled phase II clinical trial, at the University of California San Diego School of Medicine report that small doses of NGM282, a non-tumorigenic variant of an endocrine gastrointestinal hormone, can significantly and rapidly decrease liver fat content in patients with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).